Crain's Chicago Business

Walgreens stock fell by as much as 10% today but was down about 6% at midday, trading at around $11.

In a move that should drive wider adoption of its cancer-testing products, Tempus AI is now an in-network provider for Blue Cross plans in six states.

The Federal Trade Commission approved the deal, one of the largest of 2024 in the industry. It is expected to close within the first quarter of 2025.

The massive investment has the potential to expand Advocate's reach, address health disparities and deliver an economic boost to the area.

PlacentaVision could offer a quick, mobile way to detect infections, like neonatal sepsis.

If state health officials approve the $375 million deal, it would put 11 Illinois hospitals and care sites under new ownership.

Tim Barry leaves the company he co-founded after failing to execute on the retail pharmacy giant's healthcare push.

Reuters is quoting unnamed sources as saying the Northfield medical products distributor is poised to have one of the biggest IPOs in recent memory.

Dr. Bobby Mukkamala plans to undergo surgery in December, the Chicago-based physicians organization said yesterday.

Under the $87 million deal, Brentwood, Tenn.-based Surgery Partners will lead operations at the suburban sites.

Now forecasting a $200 million sales hit in the fourth quarter, the company’s shares are sliding.

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

This is the latest batch of cuts made by the struggling retail pharmacy chain in the last year and a half.

The health system is bringing on a St. Louis nursing exec to replace Mary Beth Kingston, marking the latest leadership role that will no longer be based in the Midwest.

Northwestern claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own researchers' technological breakthroughs.